Female Fertility And Pregnancy Rapid Test Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Female Fertility And Pregnancy Rapid Test by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Female Fertility And Pregnancy Rapid Test Market:

https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

According to The Business Research Company’s Female Fertility And Pregnancy Rapid Test, The female fertility and pregnancy rapid test market size has grown strongly in recent years. It will grow from $1.35 billion in 2023 to $1.44 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%.  The  growth in the historic period can be attributed to increased awareness of reproductive health, delay in childbearing age, cultural and societal changes, rising maternal age, over-the-counter availability..

The female fertility and pregnancy rapid test market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.  The growth in the forecast period can be attributed to personalized medicine approaches, rising interest in natural family planning, global fertility tourism, government initiatives for family planning, affordable healthcare initiatives.. Major trends in the forecast period include digital health integration,  telemedicine adoption, partnerships and collaborations in the healthcare industry, online retail channels for test kit sales, innovations in ovulation prediction tests..

The increasing incidence of gynecological disorders is expected to propel the growth of the female fertility and pregnancy rapid test market going forward. A gynecological problem is a medical ailment that affects the female reproductive organs, specifically the breasts and abdominal and pelvic organs such as the womb (uterus), ovaries, vagina, fallopian tubes, and vulva. Fertility testing can be performed to identify ovulation and/or to diagnose infertility, which is defined as the inability to procreate naturally which in turn helps in reducing gynecological disorders. For instance, in July 2022, according to a report published by the National Library of Medicine, a US-based medical library, the prevalence of gynecological disorders include disposable uterine fibroids (14.23%), spontaneous abortion (13.20%), ovarian dysfunction (11.16%), endometriosis (4.09%), polycystic ovary syndrome (19.04%), and dysmenorrhea (45.96%). Therefore, the increasing incidence of gynecological disorders is driving the growth of the female fertility and pregnancy rapid test market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8966&type=smp

The female fertility and pregnancy rapid test market covered in this report is segmented –

1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits

2) By Device Type: Digital Devices, Line-indicator Devices

3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test

4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel

Product innovations are the key trend gaining popularity in the female fertility and pregnancy rapid test market. Major companies are developing innovative test kits to sustain their position in the market. For instance, in November 2022, Salignostics, Israel-based research, and development firm specializing in the development of saliva-based rapid diagnostic assays launched Sailstick, a saliva-based pregnancy test. Salistick is the first rapid saliva-based pregnancy test with an improved user interface and high accuracy for detecting early pregnancy. The kit is based on the company’s ground-breaking technology for detecting the pregnancy hormone -HCG in saliva. People who take the test enter one component of the test kit into their mouth for several seconds to collect saliva and then into a testing tube, which produces results in less than 10 minutes.

The female fertility and pregnancy rapid test market report table of contents includes:

 

1. Executive Summary
2. Female Fertility And Pregnancy Rapid Test Market Characteristics
3. Female Fertility And Pregnancy Rapid Test Market Trends And Strategies
4. Female Fertility And Pregnancy Rapid Test Market – Macro Economic Scenario
5. Global Female Fertility And Pregnancy Rapid Test Market Size and Growth

.

.

.

31. Global Female Fertility And Pregnancy Rapid Test Market Competitive Benchmarking
32. Global Female Fertility And Pregnancy Rapid Test Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Female Fertility And Pregnancy Rapid Test Market
34. Female Fertility And Pregnancy Rapid Test Market Future Outlook and Potential Analysis
35. Appendix

Top Major Players:

 

• Abbott Laboratories
• Atlas Medical GmbH
• bioMérieux SA
• Church & Dwight Co. Inc.
• Quidel Corporation

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany  

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/  

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model